“Unfortunately, these treatments have substantial sequelae, including the possibility of causing … blood component products.3 Mannucci and coworkers4 found that administration of DDAVP (I-desamino-8-d-arginine vasopressin, desmopressin) to … fourto six-fold elevation of F VIII : C and F VIII : VWF in … greater than 5% of normal).”